Background
This is the statistical analysis presented in the manuscript "Implications of current therapeutic restrictions for primaquine and tafenoquine in the radical cure of vivax malaria", Watson et al 
Load the data
Read in the first 8 rows of the extracted meta data:
rm(list = ls()) meta_data = readxl::read_excel( Extracted_Summary_Data.xlsx ) [1:8,] 
Categorisation of genotypes
In order to partially correct for the over-dispersion in the meta-data, we classify the data into two groups representing levels of severity of G6PD deficient alleles. Our hypothesis is that the deficient allele confers varying average G6PD activities in heterozygous females.
One way of separating out the different levels of severity is by looking at the ratio of hemizygote or homozygous G6PD normals to that of hemizygote or homozygote deficients: This is only possible for six of the studies due to missing meta-data. We impute for the remaining two studies (both Mahidol).
Bayesian beta-binomial model
We use the rethinking package which allows for simple specification of hierachical models which are then fitted using stan. Specification of the beta binomial model and fitting via stan. We choose the following priors:
library(rethinking)
• The beta parameter for each genotype is given a weakly informative prior centered at 0 (this corresponds to 50%) • The dispersion parameter is given an exponential prior centered at 2 (rate=1/2). Values above 2 correspond to concentrated (non-dispersed) beta-binomial distributions; values less than 2 correspond to dispersed beta-binomials.
Specification of the model using the map2stan function from the rethinking package, and then model fitting using stan. Look at the two genotype-dependent coefficients determining the value of the beta-binomial posterior. We compute the centered 90% credible intervals. Look at the two genotype-dependent coefficients determining the value of the beta-binomial posterior. We compute the centered 90% credible intervals. 
